Mercer Global Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$619K Sell
13,400
-68
-0.5% -$2.74K ﹤0.01% 2105
2026
Q1
$446K Sell
13,468
-2,389
-15% -$77.7K ﹤0.01% 2068
2025
Q4
$503K Buy
15,857
+4,664
+42% +$115K ﹤0.01% 1858
2025
Q3
$200K Buy
11,193
+1,173
+12% +$17K ﹤0.01% 2394
2025
Q2
$109K Buy
+10,020
New +$131K ﹤0.01% 2150
2021
Q2
Sell
-25,024
Closed -$507K 1676
2021
Q1
$507K Hold
25,024
﹤0.01% 1071
2020
Q4
$448K Hold
25,024
0.01% 909
2020
Q3
$291K Hold
25,024
﹤0.01% 980
2020
Q2
$231K Hold
25,024
﹤0.01% 944
2020
Q1
$260K Hold
25,024
0.01% 853
2019
Q4
$448K Sell
25,024
-10
-0% -$148 0.01% 770
2019
Q3
$312K Buy
+25,034
New +$412K 0.01% 870

Other funds holding AXGN

Mercer Global Advisors's AXGN Position: Q2 2026 in Review

Mercer Global Advisors reduced its Axogen (AXGN) stake by 0.5% in Q2 2026, selling an estimated $2.74K and leaving 13,400 shares worth $619K. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Mercer Global Advisors first reported a position in AXGN in Q3 2019 and has held it in 12 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Mercer Global Advisors held 13,400 shares of Axogen worth $619K as of Q2 2026.
  • Mercer Global Advisors sold 68 Axogen shares in Q2 2026, an estimated $2.74K.
  • Axogen made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2105 holding.
  • Mercer Global Advisors first reported a position in Axogen in Q3 2019 and has held it in 12 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.